Jue Yang1,2, Hui Song3,4, Li Chen5, Kun Cao6, Yongqiang Zhang7, Yanmei Li1,2, Xiaojiang Hao1,2. 1. The State Key Laboratory of Functions & Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, PR China. 2. The Key Laboratory of Chemistry for Natural Products of Guizhou Province & Chinese Academic of Sciences, Guiyang 550014, PR China. 3. The Key Laboratory of Endemic & Ethnic Diseases, Guizhou Medical University, Ministry of Education, Guiyang 550004, PR China. 4. The Key Laboratory of Medical Molecular Biology, Guizhou Medical University, Guizhou Province, Guiyang 550004, PR China. 5. Guiyang University of Chinese Medicine, School of Pharmaceutical Sciences, Guiyang 550025, PR China. 6. Department of General Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang 550001, PR China. 7. Guizhou University, School of Pharmaceutical Sciences, Guiyang, 550025, PR China.
Abstract
AIM: The potential functions and underlying mechanism of microfibrillar-associated proteins (MFAPs) are explored in human cancers. MATERIALS & METHODS: Here, we examined the expression profiles, prognostic values, epigenetic and genetic alterations of MFAPs in human cancers from public omics repository. RESULTS: Among MFAPs family, MFAP4 was frequently downregulated in the most human cancers and high mRNA expression of MFAP4 significantly correlated with better overall survival in breast cancer. DNA hypermethylation in the promoter of MFAP4 decreased its mRNA expression. MFAP4 strongly associated with pathway in impairment and alteration of the elastic fibers. CONCLUSION: This integrated analysis provides new insights into MFAPs in human cancers and indicates that MFAP4 could be used as novel biomarker for developing therapies against human cancers.
AIM: The potential functions and underlying mechanism of microfibrillar-associated proteins (MFAPs) are explored in human cancers. MATERIALS & METHODS: Here, we examined the expression profiles, prognostic values, epigenetic and genetic alterations of MFAPs in human cancers from public omics repository. RESULTS: Among MFAPs family, MFAP4 was frequently downregulated in the most human cancers and high mRNA expression of MFAP4 significantly correlated with better overall survival in breast cancer. DNA hypermethylation in the promoter of MFAP4 decreased its mRNA expression. MFAP4 strongly associated with pathway in impairment and alteration of the elastic fibers. CONCLUSION: This integrated analysis provides new insights into MFAPs in human cancers and indicates that MFAP4 could be used as novel biomarker for developing therapies against human cancers.
Entities:
Keywords:
DNA methylation; TCGA; breast cancer; microfibrillar-associated protein 4; overall survival
Authors: Thai-Vu T Ton; Ramesh C Kovi; Teja N Peddada; Raveena M Chhabria; Keith R Shockley; Norris D Flagler; Kevin E Gerrish; Ronald A Herbert; Mamta Behl; Mark J Hoenerhoff; Robert C Sills; Arun R Pandiri Journal: Arch Toxicol Date: 2021-09-01 Impact factor: 6.168
Authors: Min Zhou; Shasha Hong; Bingshu Li; Cheng Liu; Ming Hu; Jie Min; Jianming Tang; Li Hong Journal: Front Genet Date: 2021-09-09 Impact factor: 4.772
Authors: Rafael Stroggilos; Maria Frantzi; Jerome Zoidakis; Marika Mokou; Napoleon Moulavasilis; Emmanouil Mavrogeorgis; Anna Melidi; Manousos Makridakis; Konstantinos Stravodimos; Maria G Roubelakis; Harald Mischak; Antonia Vlahou Journal: Cancers (Basel) Date: 2022-05-21 Impact factor: 6.575